nafamostat and pyrazines

nafamostat has been researched along with pyrazines in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's6 (100.00)2.80

Authors

AuthorsStudies
Doi, K; Hayase, N; Ikeda, M; Morimura, N; Moriya, K1
Hifumi, T; Ishimatsu, S; Isokawa, S; Otani, N1
Inoue, KI; Sagawa, T; Takano, H1
Fujii, H; Hiraoka, N; Horiguchi, M; Matsuyama, A; Omura, A; Ono, S; Shiotsu, S; Suga, Y; Takumi, C; Tanaka, S; Tsuji, T; Yuba, T1
Fätkenheuer, G; Malin, JJ; Rybniker, J; Simonis, A; Theobald, SJ1
Atsumi, T; Cho, KY; Inoshita, N; Kamada, K; Kameda, H; Kenmotsu, Y; Konno, S; Miyoshi, H; Nakakubo, S; Nakamura, A; Nakamura, J; Nomoto, H; Sawamura, Y; Shimatsu, A; Sugino, H; Suzuki, M; Takahashi, Y; Yamashita, Y; Yuno, A1

Reviews

2 review(s) available for nafamostat and pyrazines

ArticleYear
High levels of anti-SSA/Ro antibodies in COVID-19 patients with severe respiratory failure: a case-based review : High levels of anti-SSA/Ro antibodies in COVID-19.
    Clinical rheumatology, 2020, Volume: 39, Issue:11

    Topics: Aged; Amides; Antibodies, Antinuclear; Antiviral Agents; Benzamidines; Betacoronavirus; Coronavirus Infections; COVID-19; Female; Glucocorticoids; Guanidines; Humans; Hydroxychloroquine; Lung Diseases, Interstitial; Male; Methylprednisolone; Pandemics; Pneumonia, Viral; Pregnenediones; Pyrazines; Recovery of Function; Respiratory Distress Syndrome; Respiratory Insufficiency; SARS-CoV-2; Severity of Illness Index; Tomography, X-Ray Computed

2020
A comparative analysis of remdesivir and other repurposed antivirals against SARS-CoV-2.
    EMBO molecular medicine, 2021, 01-11, Volume: 13, Issue:1

    Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Benzamidines; COVID-19 Drug Treatment; Drug Repositioning; Esters; Guanidines; Guanine; Humans; Indoles; Lopinavir; Protease Inhibitors; Pyrazines; Ribavirin; Ritonavir; SARS-CoV-2; Virus Internalization; Virus Replication

2021

Other Studies

4 other study(ies) available for nafamostat and pyrazines

ArticleYear
Nafamostat mesylate treatment in combination with favipiravir for patients critically ill with Covid-19: a case series.
    Critical care (London, England), 2020, 07-03, Volume: 24, Issue:1

    Topics: Aged; Amides; Benzamidines; Coronavirus Infections; COVID-19 Drug Treatment; Critical Illness; Drug Therapy, Combination; Female; Guanidines; Humans; Male; Middle Aged; Pyrazines; Treatment Outcome

2020
Adverse events associated with nafamostat mesylate and favipiravir treatment in COVID-19 patients.
    Critical care (London, England), 2020, 08-12, Volume: 24, Issue:1

    Topics: Amides; Benzamidines; Betacoronavirus; Coronavirus Infections; COVID-19; Critical Illness; Guanidines; Humans; Pandemics; Pneumonia, Viral; Pyrazines; SARS-CoV-2

2020
Preventing the clinical manifestations and disease progression of coronavirus disease using clinically proven protease inhibitors.
    Critical care (London, England), 2020, 08-18, Volume: 24, Issue:1

    Topics: Amides; Benzamidines; Betacoronavirus; Coronavirus; Coronavirus Infections; COVID-19; Critical Illness; Disease Progression; Guanidines; Humans; Pandemics; Pneumonia, Viral; Protease Inhibitors; Pyrazines; SARS-CoV-2

2020
Successful management of a patient with active Cushing's disease complicated with coronavirus disease 2019 (COVID-19) pneumonia.
    Endocrine journal, 2021, Apr-28, Volume: 68, Issue:4

    Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Adult; Amides; Benzamidines; Combined Modality Therapy; COVID-19; Dihydrotestosterone; Disease Progression; Female; Guanidines; Health Personnel; Heparin; Humans; Japan; Metyrapone; Neurosurgical Procedures; Pituitary ACTH Hypersecretion; Pregnenediones; Pyrazines; SARS-CoV-2; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination

2021